|
FcγRIIa: A Novel Marker of Cardiovascular Risk
Increased platelet reactivity has been associated with a greater risk of cardiovascular events. Despite this consistent association, individualized anti-platelet therapy, guided by platelet function testing has not yet shown to reduce the risk of cardiovascular events and intra-individual variability of the current indirect platelet function tests has...
Published: 2/25/2025
|
Inventor(s): David John Schneider*
Keywords(s):
Category(s): Technology Classifications > Biomedical
|
